GE HealthCare Technologies (GEHC) – Investment Analysts’ Weekly Ratings Changes

GE HealthCare Technologies (NASDAQ: GEHC) has recently received a number of price target changes and ratings updates:

• 12/29/2025 – GE HealthCare Technologies had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – GE HealthCare Technologies had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – GE HealthCare Technologies had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/11/2025 – GE HealthCare Technologies had its price target raised by analysts at Jefferies Financial Group Inc. from $95.00 to $105.00. They now have a “buy” rating on the stock.
• 12/11/2025 – GE HealthCare Technologies had its price target raised by analysts at Citigroup Inc. from $83.00 to $88.00. They now have a “neutral” rating on the stock.
• 12/1/2025 – GE HealthCare Technologies had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/21/2025 – GE HealthCare Technologies was given a new $90.00 price target on by analysts at Stifel Nicolaus.
• 11/21/2025 – GE HealthCare Technologies had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $87.00 price target on the stock.
• 11/17/2025 – GE HealthCare Technologies had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/11/2025 – GE HealthCare Technologies had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.